<?xml version="1.0" ?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:media="http://search.yahoo.com/mrss/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:seo="http://purl.org/seo/elements/1.0/" version="2.0">
	<channel>
		<title>TMX Newsfile Health News Releases</title>
		<link>https://feeds.newsfilecorp.com/industry/health</link>
		<description>Last 10 Health news releases from TMX Newsfile. Contact us for a custom full-bodied RSS feed complete with exchange and ticker data.</description>
		<language>en</language>
		<copyright>CopyRight (c) 2026, Newsfile Corp. All Rights Reserved.</copyright>
		<managingEditor>office@newsfilecorp.com (Newsfile Corp.)</managingEditor>
		<webMaster>office@newsfilecorp.com (Newsfile Corp.)</webMaster>
		<lastBuildDate>Fri, 23 Oct 2026 20:37:12 -0400</lastBuildDate>
		<image>
			<url>https://www.newsfilecorp.com/images/tmx-newsfile-wire-logo.png</url>
			<title>TMX Newsfile Health News Releases</title>
			<link>https://feeds.newsfilecorp.com/industry/health</link>
		</image>
		<atom:link rel="self" type="application/rss+xml" href="https://feeds.newsfilecorp.com/industry/health"/>
		<item xml:lang="en">
			<title>Therma Bright Announces up to $420,000 Non-Brokered Private Placement</title>
			<link>https://www.newsfilecorp.com/release/320783/Therma-Bright-Announces-up-to-420000-NonBrokered-Private-Placement</link>
			<description>&lt;img src="https://api.newsfilecorp.com/newsinfo/320783/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;Toronto, Ontario--(Newsfile Corp. - October 23, 2026) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX0) ("Therma" or the "Company"), a developer and investment partner specializing in advanced medical device technologies, announces that it proposes to undertake a non-brokered private placement of up to 14,000,000 common shares (the "Shares") at a price of $0.03/Share for total proceeds of up to $420,000 (the "Offering").  In accordance with the policies of the TSX Venture Exchange...</description>
			<pubDate>Fri, 23 Oct 2026 20:37:00 -0400</pubDate>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/320783/Therma-Bright-Announces-up-to-420000-NonBrokered-Private-Placement</guid>
		</item>
		<item xml:lang="en">
			<title>Unbuzzd Wellness Announces Closing of Private Placement Financing</title>
			<link>https://www.newsfilecorp.com/release/320749/Unbuzzd-Wellness-Announces-Closing-of-Private-Placement-Financing</link>
			<description>&lt;img src="https://api.newsfilecorp.com/newsinfo/320749/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;Vancouver, British Columbia--(Newsfile Corp. - October 23, 2026) - Unbuzzd Wellness Inc. (the "Company" or "Unbuzzd"), the company behind unbuzzd™, is pleased to announce that it has completed its non-brokered private placement financing (the "Offering") in two tranches for aggregate gross proceeds of $1,080,000 through the issuance of an aggregate of 5,400,000 common shares in the share capital of the Company (the "Shares") at a price of $0.20 per Share.The Company closed the first tranche of...</description>
			<pubDate>Fri, 23 Oct 2026 19:00:00 -0400</pubDate>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/320749/Unbuzzd-Wellness-Announces-Closing-of-Private-Placement-Financing</guid>
		</item>
		<item xml:lang="en">
			<title>Defence Therapeutics Announces Convertible Debenture Interest Payment</title>
			<link>https://www.newsfilecorp.com/release/320679/Defence-Therapeutics-Announces-Convertible-Debenture-Interest-Payment</link>
			<description>&lt;img src="https://api.newsfilecorp.com/newsinfo/320679/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;Montreal, Quebec--(Newsfile Corp. - October 23, 2026) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a publicly traded biotechnology company developing next-generation precision oncology therapeutics using its proprietary Accum® drug-delivery platform, is pleased to announce convertible debentures interest payment in common shares of the Company.  The Company announces that, in accordance with the terms and conditions of convertible debentures...</description>
			<pubDate>Fri, 23 Oct 2026 16:15:00 -0400</pubDate>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/320679/Defence-Therapeutics-Announces-Convertible-Debenture-Interest-Payment</guid>
		</item>
		<item xml:lang="en">
			<title>PreveCeutical Closes Initial Tranche of Non-Brokered Private Placement</title>
			<link>https://www.newsfilecorp.com/release/320512/PreveCeutical-Closes-Initial-Tranche-of-NonBrokered-Private-Placement</link>
			<description>&lt;img src="https://api.newsfilecorp.com/newsinfo/320512/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;Vancouver, British Columbia--(Newsfile Corp. - October 22, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0) (the "Company" or "PreveCeutical"), is pleased announce that, further to its news release dated September 28, 2026, it has closed an initial tranche (the "Initial Tranche") of its previously announced $600,000 non-brokered private placement (the "Offering"), which Initial Tranche consisted of the issuance of 5,200,000 units (each, a "Unit") of the Company at a...</description>
			<pubDate>Thu, 22 Oct 2026 17:24:00 -0400</pubDate>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/320512/PreveCeutical-Closes-Initial-Tranche-of-NonBrokered-Private-Placement</guid>
		</item>
		<item xml:lang="en">
			<title>Rise Nano Optics Announces Proposed Non-Brokered Private Placement of Up to C$5 Million</title>
			<link>https://www.newsfilecorp.com/release/320352/Rise-Nano-Optics-Announces-Proposed-NonBrokered-Private-Placement-of-Up-to-C5-Million</link>
			<description>&lt;img src="https://api.newsfilecorp.com/newsinfo/320352/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;Financing intended to accelerate SpectraGuard™ commercialization, expand optical industry partnerships and support manufacturing growthNOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESRecent Highlights: FDA Registration: Rise successfully completed FDA Class 1 Medical Device Classification and Registration for SpectraGuard.Two Optical Lab Partnerships: Established strategic partnerships with Sierra Optical Lab and Sportifeye Optics in the USA to...</description>
			<pubDate>Thu, 22 Oct 2026 07:00:00 -0400</pubDate>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/320352/Rise-Nano-Optics-Announces-Proposed-NonBrokered-Private-Placement-of-Up-to-C5-Million</guid>
		</item>
		<item xml:lang="en">
			<title>TelyRx to Host Third Quarter 2026 Financial Results Conference Call on Friday, November 6, 2026 at 8:30 am ET</title>
			<link>https://www.newsfilecorp.com/release/320240/TelyRx-to-Host-Third-Quarter-2026-Financial-Results-Conference-Call-on-Friday-November-6-2026-at-830-am-ET</link>
			<description>&lt;img src="https://api.newsfilecorp.com/newsinfo/320240/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;Clearwater, Florida--(Newsfile Corp. - October 22, 2026) - TelyRx Holdings Inc. (TSX: TELY) (OTCQX: TELYF) ("TelyRx" or the "Company"), a vertically integrated, technology-enabled healthcare and pharmacy services company, today announced it will host a conference call and webcast to discuss its third quarter 2026 financial results on Friday, November 6, 2026, at 8:30 a.m. Eastern Time (ET). The Company expects to report its third quarter 2026 financial results for the period ended September 30,...</description>
			<pubDate>Thu, 22 Oct 2026 07:00:00 -0400</pubDate>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/320240/TelyRx-to-Host-Third-Quarter-2026-Financial-Results-Conference-Call-on-Friday-November-6-2026-at-830-am-ET</guid>
		</item>
		<item xml:lang="en">
			<title>The Untold Story of Rick Hansen's Man In Motion World Tour Comes to the Big Screen Across Canada in November</title>
			<link>https://www.newsfilecorp.com/release/320138/The-Untold-Story-of-Rick-Hansens-Man-In-Motion-World-Tour-Comes-to-the-Big-Screen-Across-Canada-in-November</link>
			<description>&lt;img src="https://api.newsfilecorp.com/newsinfo/320138/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;Richmond, British Columbia--(Newsfile Corp. - October 21, 2026) - Man In Motion: The Rick Hansen Story will be a special event release by Cineplex in selected theatres  across Canada on November 1 and 3. Tickets are now on sale. The theatrical release follows the film's world premiere at the Toronto International Film Festival (TIFF), where it received an honourable mention for the Best Canadian Feature Film Award, and its hometown premiere at the Vancouver International Film Festival (VIFF)....</description>
			<pubDate>Wed, 21 Oct 2026 10:20:00 -0400</pubDate>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/320138/The-Untold-Story-of-Rick-Hansens-Man-In-Motion-World-Tour-Comes-to-the-Big-Screen-Across-Canada-in-November</guid>
			<atom:subtitle>Tickets are now on sale for Man In Motion: The Rick Hansen Story at theatres from coast to coast - an intimate look behind the historic journey through never-before-seen footage and Rick Hansen's private audio diaries.</atom:subtitle>
		</item>
		<item xml:lang="en">
			<title>Rapid Dose Therapeutics Ships QuickStrip(TM) Production Line to Callan JMB's Texas cGMP Facility</title>
			<link>https://www.newsfilecorp.com/release/320149/Rapid-Dose-Therapeutics-Ships-QuickStripTM-Production-Line-to-Callan-JMBs-Texas-cGMP-Facility</link>
			<description>&lt;img src="https://api.newsfilecorp.com/newsinfo/320149/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;Burlington, Ontario--(Newsfile Corp. - October 21, 2026) - Rapid Dose Therapeutics Corp. (CSE: DOSE) (OTCQB: RDTCF) ("RDT" or the "Company"), a Canadian biotechnology company specializing in oral thin-film drug delivery technology, today announced that it has shipped a complete QuickStrip™ production line to Callan JMB Inc. (NASDAQ: CJMB) ("Callan JMB") for planned installation at its cGMP facility in Texas, United States.The shipment advances the collaboration outlined in Callan JMB's November...</description>
			<pubDate>Wed, 21 Oct 2026 09:16:00 -0400</pubDate>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/320149/Rapid-Dose-Therapeutics-Ships-QuickStripTM-Production-Line-to-Callan-JMBs-Texas-cGMP-Facility</guid>
		</item>
		<item xml:lang="en">
			<title>HPN Holdings, Inc. (KICK) Announces Orange Insurance Services' Continued Agent Growth and Planned Texas Expansion for Q1 2027</title>
			<link>https://www.newsfilecorp.com/release/320147/HPN-Holdings-Inc.-KICK-Announces-Orange-Insurance-Services-Continued-Agent-Growth-and-Planned-Texas-Expansion-for-Q1-2027</link>
			<description>&lt;img src="https://api.newsfilecorp.com/newsinfo/320147/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;Oak Brook, Illinois--(Newsfile Corp. - October 21, 2026) - Orange Underwriters, LLC DBA Orange Insurance Services ("Orange"), a technology-driven provider of non-standard automobile insurance, today announced that its growth in appointed insurance agencies continues to significantly exceed the company's original targets. Building on that momentum, Orange also announced plans to expand into Texas during the first quarter of 2027.Since launching operations in Florida, Orange has experienced strong...</description>
			<pubDate>Wed, 21 Oct 2026 09:00:00 -0400</pubDate>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/320147/HPN-Holdings-Inc.-KICK-Announces-Orange-Insurance-Services-Continued-Agent-Growth-and-Planned-Texas-Expansion-for-Q1-2027</guid>
			<atom:subtitle>Agent appointments continue to exceed expectations as Orange prepares to leverage its technology platform and established agent relationships for rapid Texas expansion</atom:subtitle>
		</item>
		<item xml:lang="en">
			<title>Custom Health to Close the Market at the TSX on October 22, 2026, and Announces Appointments of Chief Commercial and Strategy Officer and Chief Compliance and Regulatory Officer</title>
			<link>https://www.newsfilecorp.com/release/320083/Custom-Health-to-Close-the-Market-at-the-TSX-on-October-22-2026-and-Announces-Appointments-of-Chief-Commercial-and-Strategy-Officer-and-Chief-Compliance-and-Regulatory-Officer</link>
			<description>&lt;img src="https://api.newsfilecorp.com/newsinfo/320083/156" id="156" width="2" height="2" style="width: 1px;  height: 1px;border: 0px solid;" /&gt;Custom Health will close the market at the Toronto Stock Exchange on October 22, 2026, to celebrate the Company's recent listing on the TSX Exchange.Mike Palackdharry has been appointed Chief Commercial and Strategy Officer, bringing more than 30 years of experience in commercial strategy, enterprise sales, business development, and strategic partnerships.Christina Garcia has been appointed Chief Compliance and Regulatory Officer, bringing more than 15 years of experience in compliance, privacy,...</description>
			<pubDate>Wed, 21 Oct 2026 06:00:00 -0400</pubDate>
			<guid isPermaLink="true">https://www.newsfilecorp.com/release/320083/Custom-Health-to-Close-the-Market-at-the-TSX-on-October-22-2026-and-Announces-Appointments-of-Chief-Commercial-and-Strategy-Officer-and-Chief-Compliance-and-Regulatory-Officer</guid>
		</item>
	</channel>
</rss>
